Loading...

LTRN LANTERN PHARMA INC Investor Conferences 8-K Filing

LNTR

LTRN

LANTERN PHARMA INC

(LTRN)

2023 8-K

Show Summary

Show Summary

Equity Offerings

Financial Statements

Financial Results

Management Changes

Q3 Results Call

Q3 Earnings Announcement

Annual Meeting of Stockholders

By-laws Amendment

Earnings Reports

Earnings Reports

Management Changes

Investment Agreement

Death of Director

Earnings Reports

Annual Meeting of Stockholders

Earnings Reports

Earnings Reports

Salary Increase

External Links:

Lantern Pharma Inc. held its 2023 Annual Meeting of Stockholders, electing directors, approving an amendment to the Equity Incentive Plan, and ratifying the appointment of EisnerAmper LLP as the independent registered public accounting firm.

AI Assistant

LANTERN PHARMA INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.